{
    "key": "2013-0499",
    "name": "#1 @ 10 yrs, MCV4",
    "cdcTestId": "2013-0499",
    "changedInVersion": "1.6",
    "dateAdded": "2013-01-01T00:00:00",
    "dateUpdated": "2020-06-01T11:15:40.166",
    "evaluation": {
        "administeredDoses": [
            {
                "cvx": "114",
                "dateAdministered": "2020-08-13T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "PMC",
                "vaccineName": "MENACTRA"
            }
        ],
        "seriesStatus": "Not complete"
    },
    "evaluationTestType": "Age: At Absolute Minimum",
    "forecast": {
        "earliestDate": "2026-08-13T00:00:00",
        "forecastNum": "2",
        "pastDueDate": "2027-09-09T00:00:00",
        "recommendedDate": "2026-08-13T00:00:00"
    },
    "forecastTestType": "Recommended based on age",
    "generalDescription": "This test case describes when dose #1 of a Mening vaccine is administered at age 10 years + 0 months that the dose is considered valid.",
    "patient": {
        "dob": "2010-08-13T00:00:00",
        "gender": "F",
        "medHistoryCode": "",
        "medHistoryCodeSys": "",
        "medHistoryText": "",
        "doses": [
            {
                "cvx": "114",
                "dateAdministered": "2020-08-13T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "PMC",
                "vaccineName": "MENACTRA"
            }
        ]
    },
    "reasonForChange": "v1.6: An EIPB clarification has resulted in a change to when dose 2 of MCV should be forecasted and validated.  The second dose must come on or after 16 years (- 4 days) of age to be considered valid.\nv1.2: Same test case as previous version rolled younger to allow for the 10 year clarification by NIPInfo",
    "testcaseName": "#1 @ 10 yrs, MCV4",
    "vaccineGroup": "MCV"
}